CYAN AG (CYR.DE) Stock Fundamental Analysis

FRA:CYR • DE000A2E4SV8

2.2 EUR
-0.06 (-2.65%)
Last: Feb 25, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CYR. CYR was compared to 112 industry peers in the Software industry. The financial health of CYR is average, but there are quite some concerns on its profitability. CYR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CYR had negative earnings in the past year.
  • CYR had a negative operating cash flow in the past year.
  • CYR had negative earnings in each of the past 5 years.
  • CYR had a negative operating cash flow in each of the past 5 years.
CYR.DE Yearly Net Income VS EBIT VS OCF VS FCFCYR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -6.26%, CYR is doing worse than 72.32% of the companies in the same industry.
  • CYR's Return On Equity of -7.08% is on the low side compared to the rest of the industry. CYR is outperformed by 64.29% of its industry peers.
Industry RankSector Rank
ROA -6.26%
ROE -7.08%
ROIC N/A
ROA(3y)-27.68%
ROA(5y)-21.43%
ROE(3y)-36.79%
ROE(5y)-28.44%
ROIC(3y)N/A
ROIC(5y)N/A
CYR.DE Yearly ROA, ROE, ROICCYR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • Looking at the Gross Margin, with a value of 84.83%, CYR is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • CYR's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CYR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
CYR.DE Yearly Profit, Operating, Gross MarginsCYR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • CYR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CYR has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CYR has been increased compared to 5 years ago.
  • Compared to 1 year ago, CYR has a worse debt to assets ratio.
CYR.DE Yearly Shares OutstandingCYR.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CYR.DE Yearly Total Debt VS Total AssetsCYR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • CYR has an Altman-Z score of 5.68. This indicates that CYR is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.68, CYR belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
  • A Debt/Equity ratio of 0.05 indicates that CYR is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.05, CYR is doing good in the industry, outperforming 77.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 5.68
ROIC/WACCN/A
WACC7.41%
CYR.DE Yearly LT Debt VS Equity VS FCFCYR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 2.24 indicates that CYR has no problem at all paying its short term obligations.
  • CYR's Current ratio of 2.24 is amongst the best of the industry. CYR outperforms 81.25% of its industry peers.
  • CYR has a Quick Ratio of 2.24. This indicates that CYR is financially healthy and has no problem in meeting its short term obligations.
  • CYR's Quick ratio of 2.24 is amongst the best of the industry. CYR outperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
CYR.DE Yearly Current Assets VS Current LiabilitesCYR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • CYR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.12%, which is quite impressive.
  • The Revenue has grown by 98.99% in the past year. This is a very strong growth!
  • Measured over the past years, CYR shows a very negative growth in Revenue. The Revenue has been decreasing by -23.31% on average per year.
EPS 1Y (TTM)86.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)98.99%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%36.96%

3.2 Future

  • Based on estimates for the next years, CYR will show a very strong growth in Earnings Per Share. The EPS will grow by 34.17% on average per year.
  • Based on estimates for the next years, CYR will show a very strong growth in Revenue. The Revenue will grow by 21.21% on average per year.
EPS Next Y78.57%
EPS Next 2Y42.5%
EPS Next 3Y17.9%
EPS Next 5Y34.17%
Revenue Next Year31.65%
Revenue Next 2Y27.23%
Revenue Next 3Y38.85%
Revenue Next 5Y21.21%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CYR.DE Yearly Revenue VS EstimatesCYR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M
CYR.DE Yearly EPS VS EstimatesCYR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • CYR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 435.64, which means the current valuation is very expensive for CYR.
  • CYR's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CYR is more expensive than 67.86% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CYR to the average of the S&P500 Index (28.03), we can say CYR is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 435.64
CYR.DE Price Earnings VS Forward Price EarningsCYR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CYR is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 126.39
CYR.DE Per share dataCYR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CYR's earnings are expected to grow with 17.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.5%
EPS Next 3Y17.9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CYR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CYAN AG

FRA:CYR (2/25/2026, 7:00:00 PM)

2.2

-0.06 (-2.65%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-25
Earnings (Next)05-13
Inst Owners1.48%
Inst Owner ChangeN/A
Ins Owners35.76%
Ins Owner ChangeN/A
Market Cap47.70M
Revenue(TTM)8.28M
Net Income(TTM)-1.96M
Analysts83.33
Price Target4.44 (101.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 435.64
P/S 5.76
P/FCF N/A
P/OCF N/A
P/B 1.72
P/tB 21.66
EV/EBITDA 126.39
EPS(TTM)-0.1
EYN/A
EPS(NY)0.01
Fwd EY0.23%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.38
BVpS1.28
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.26%
ROE -7.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.83%
FCFM N/A
ROA(3y)-27.68%
ROA(5y)-21.43%
ROE(3y)-36.79%
ROE(5y)-28.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 3.19
Cap/Depr 1.57%
Cap/Sales 0.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 5.68
F-Score5
WACC7.41%
ROIC/WACCN/A
Cap/Depr(3y)16.18%
Cap/Depr(5y)14.33%
Cap/Sales(3y)12.45%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y78.57%
EPS Next 2Y42.5%
EPS Next 3Y17.9%
EPS Next 5Y34.17%
Revenue 1Y (TTM)98.99%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%36.96%
Revenue Next Year31.65%
Revenue Next 2Y27.23%
Revenue Next 3Y38.85%
Revenue Next 5Y21.21%
EBIT growth 1Y-16.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.39%
EBIT Next 3Y54.15%
EBIT Next 5Y30.52%
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.64%
OCF growth 3YN/A
OCF growth 5YN/A

CYAN AG / CYR.DE FAQ

What is the ChartMill fundamental rating of CYAN AG (CYR.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CYR.DE.


What is the valuation status for CYR stock?

ChartMill assigns a valuation rating of 0 / 10 to CYAN AG (CYR.DE). This can be considered as Overvalued.


What is the profitability of CYR stock?

CYAN AG (CYR.DE) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for CYR stock?

The Earnings per Share (EPS) of CYAN AG (CYR.DE) is expected to grow by 78.57% in the next year.